IMPROVING THE TREATMENT OF CORONAVIRUS INFECTION COVID-19
N. T. NurmatovaAssistant, basic doctoral student of the Department of Normal and Pathological Physiology of the Tashkent Medical Academy , UzbekistanBakhtiyor U. IriskulovDSc, Professor, Head of the Department of Normal and Pathological Physiology , Tashkent Medical Academy , UzbekistanOzoda Z. SaydalikhodjaevaPhD, Associate professor of the Department of Normal and Pathological Physiology , Tashkent Medical Academy , UzbekistanZukhra N. BoboevaPhD, senior lecture of the Department of Normal and Pathological Physiology , Tashkent Medical Academy , UzbekistanAzimova, S.B.Gulchekhra E. UsmonovaPhD, assistant of the Department of Normal and Pathological Physiology , Tashkent Medical Academy , Uzbekistan
2023en
Ochiq kirishBronza
ABI
Annotatsiya
This article provides data on a new method of treating coronavirus infection COVID-19 with a mixture of Ganoderma Lucidum and Alhadai. When performing PCR diagnostics, 110 copies / ml were found in the blood of rats on days 5-6, which indicates high levels of the virus in the respiratory tract. The viral RNA detection rate was 95%. Ganoderma Lucidum contains a large number of amino acids, both essential and non-essential, which bind to the protease domain of ACE 2 or to the S-protein of SARS CoV-2 and prevent the two substances from binding. Thus, there is no excessive accumulation of angiotensin II, which, through the activation of AT1R (angiotensin II receptor type I), leads to acute lung injury.
Hali tarjima qilinmagan
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba